SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form POS AM - Post-Effective amendments for registration statement:
SEC Accession No. 0001214659-23-007828
Filing Date
2023-05-25
Accepted
2023-05-25 16:39:58
Documents
5

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 2 p522230posam2.htm POS AM 463702
2 EXHIBIT 23.1 ex23_1.htm EX-23.1 5772
3 GRAPHIC biodexa_logo.jpg GRAPHIC 13595
4 GRAPHIC chart.jpg GRAPHIC 109774
5 GRAPHIC mazars_logomed.jpg GRAPHIC 10264
  Complete submission text file 0001214659-23-007828.txt   654985
Mailing Address 1 CASPIAN POINT CASPIAN WAY CARDIFF X0 CF10 4DQ
Business Address 1 CASPIAN POINT CASPIAN WAY CARDIFF X0 CF10 4DQ 44 (0)1235 888300
Biodexa Pharmaceuticals Plc (Filer) CIK: 0001643918 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: POS AM | Act: 33 | File No.: 333-270353 | Film No.: 23961441
SIC: 2834 Pharmaceutical Preparations